selected scholarly activity
-
academic article
- Safety and efficacy of nabilone for acute chemotherapy-induced vomiting prophylaxis in pediatric patients: A multicenter, retrospective review. Pediatric Blood and Cancer Medical and Pediatric Oncology. 65:e27374-e27374. 2018
- American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. Blood Adv. 2:3292-3316. 2018
- Effect of Levofloxacin Prophylaxis on Bacteremia in Children With Acute Leukemia or Undergoing Hematopoietic Stem Cell Transplantation. JAMA - Journal of the American Medical Association. 320:995-995. 2018
- Guideline for the prevention of oral and oropharyngeal mucositis in children receiving treatment for cancer or undergoing haematopoietic stem cell transplantation. BMJ Supportive and Palliative Care. 7:7-16. 2017
- Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial. The Lancet Oncology. 18:63-74. 2017
- Fanconi Syndrome Secondary to Deferasirox in Diamond-Blackfan Anemia: Case Series and Recommendations for Early Diagnosis. Pediatric Blood and Cancer Medical and Pediatric Oncology. 63:1480-1483. 2016
- Regulatory and logistical issues influencing access to antineoplastic and supportive care medications for children with cancer in developing countries. Pediatric Blood and Cancer Medical and Pediatric Oncology. 61:1513-1517. 2014
- Evaluation of the Use of Low-Molecular-Weight Heparin in Neonates. Clinical and Applied Thrombosis/Hemostasis. 19:488-493. 2013
- Essential medicines for pediatric oncology in developing countries. Pediatric Blood and Cancer Medical and Pediatric Oncology. 60:889-891. 2013
- Bisphosphonate Therapy for Reduced Bone Mineral Density During Treatment of Acute Lymphoblastic Leukemia in Childhood and Adolescence. Journal of Pediatric Hematology/Oncology. 29:613-616. 2007
- Reversal of anti-thrombin activity using protamine sulfate. Experience in a neonate with a 10-fold overdose of enoxaparin. Thrombosis Research. 120:303-305. 2007
- The use of low molecular weight heparins in pediatrics: Two cases that highlight potential risks to patient safety. Thrombosis Research. 121:281-282. 2007
- Comment on ASCO-ESMO Consensus Statement on Quality Cancer Care. Journal of Clinical Oncology. 24:5613-5614. 2006
- Thromboembolic complications in children with cancer. Thrombosis Research. 118:137-152. 2006
- Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin’s lymphoma: results of a pilot study. Journal of Oncology Pharmacy Practice. 11:51-56. 2005
- A formulary for pediatric oncology in developing countries. Pediatric Blood and Cancer Medical and Pediatric Oncology. 44:433-435. 2005
- Osteopenia in children with acute lymphoblastic leukemia: A pilot study of amelioration with pamidronate. Pediatric Blood and Cancer Medical and Pediatric Oncology. 39:44-46. 2002
- Prospective evaluation of a policy of early discontinuation of antibiotics and discharge from hospital in children with cancer who develop fever. Journal of Oncology Pharmacy Practice. 6:131-137. 2001
- A preoperative protocol for the prevention of infection in children with tunnelled right atrial catheters.. Oncology Reports. 7:1239-1242. 2000
- Stability and sterility of recombinant tissue plasminogen activator at −30°C. The Lancet. 355:2221-2221. 2000
- Prospective evaluation of a policy of early discontinuation of antibiotics and discharge from hospital in children with cancer who develop fever. Journal of Oncology Pharmacy Practice. 6:131-137. 2000
- Open-label comparison of the antiemetic efficacy of single intravenous doses of dolasetron mesylate in pediatric cancer patients receiving moderately to highly emetogenic chemotherapy. Pediatric Blood and Cancer Medical and Pediatric Oncology. 33:99-105. 1999
- Open‐label comparison of the antiemetic efficacy of single intravenous doses of dolasetron mesylate in pediatric cancer patients receiving moderately to highly emetogenic chemotherapy. Pediatric Blood and Cancer Medical and Pediatric Oncology. 33:99-105. 1999
- Bacterial Colonization of Tunneled Right Atrial Catheters in Pediatric Oncology. Journal of Pediatric Hematology/Oncology. 13:137-140. 1991
- Evaluation of a Home Intravenous Antibiotic Program in Pediatric Oncology. Journal of Pediatric Hematology/Oncology. 13:144-147. 1991
- Free and Liposomal Doxorubicin Treatment of Intraperitoneal Colon 26 Tumor: Therapeutic and Pharmacologic Studies. Selective Cancer Therapeutics. 6:193-209. 1990
-
conference paper
- IBRUTINIB FOR CHRONIC LYMPHOCYTIC LEUKEMIA: IMPACT OF THE CANADIAN YOU & PATIENT SUPPORT PROGRAM ON TREATMENT ADHERENCE. Haematologica. 419-420. 2017
- IBRUTINIB FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): IMPACT OF THE YOU & PATIENT SUPPORT PROGRAM ON TREATMENT ADHERENCE. Haematologica. 444-445. 2016
- ADVANCING DIAGNOSIS AND TREATMENT OF NEUROBLASTOMA FOR CHILDREN IN LOW INCOME COUNTRIES (LIC) VIA WEB-BASED TUMOR BOARD PLATFORM. Pediatric Blood and Cancer Medical and Pediatric Oncology. 733-733. 2011
- EVALUATION OF SAFE CHEMOTHERAPY HANDLING IN THE PARTICIPATING CENTERS OF THE CENTRAL AMERICAN AND DOMINICAN REPUBLIC ASSOCIATION OF PEDIATRIC HEMATOLOGY-ONCOLOGY. Pediatric Blood and Cancer Medical and Pediatric Oncology. 950-951. 2010
- REVIEW AND ANALYSIS OF POSITIVE BLOOD CULTURES IN 248 CHILDREN DIAGNOSED WITH CANCER. Pediatric Blood and Cancer Medical and Pediatric Oncology. 867-867. 2009
- Use of alendronate to treat reduced bone mineral mass in children surviving acute lymphoblastic leukemia (ALL). Bone. S85-S86. 2005
- Effects of pamidronate infusion to reverse observed abnormalities in bone metabolism and mineral mass in children during chemotherapy for acute lymphoblastic leukemia.. Journal of Bone and Mineral Research. S581-S581. 2000